Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2
Status:
COMPLETED
Trial end date:
2024-06-19
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blind, Multi-center, Placebo-controlled, Phase III Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2 Add-on to Metformin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Sitagliptin Combination Therapy